Sign In
Buy ACT
$40.57
-0.580 (-1.41%)
At Close: Jun 03, 2026
Enact Provides Update on Capital Position Under New PMIERs Available Asset Guidelines
06:40pm, Wednesday, 21'st Aug 2024
RALEIGH, N.C., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact), a leading provider of private mortgage insurance through its insurance subsidiaries, today addressed the up
Enact Re, Ltd. Receives A- Rating from S&P Global Ratings
05:06pm, Monday, 19'th Aug 2024
First Rating Assigned to Enact Re by S&P and Second Rating Since Launch Underscores Continued Strong Performance First Rating Assigned to Enact Re by S&P and Second Rating Since Launch Underscores Con
CSE Bulletin: Consolidation - Aduro Clean Technologies Inc. (ACT)
10:34am, Monday, 19'th Aug 2024
Toronto, Ontario--(Newsfile Corp. - Le 19 août/August 2024) - Aduro Clean Technologies Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-cons
New Strong Buy Stocks for August 7th
06:55am, Wednesday, 07'th Aug 2024
GRC, HGTY, APOG, AER and ACT have been added to the Zacks Rank #1 (Strong Buy) List on August 7, 2024.
- Newly issued U.S. patent augments Actinium's existing composition of matter patent coverage over Iomab-B and Iomab-ACT targeted radiotherapy conditioning programs - Pertains
Enact Holdings, Inc. (ACT) Surpasses Q2 Earnings Estimates
07:40pm, Wednesday, 31'st Jul 2024
Enact Holdings, Inc. (ACT) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $1.10 per share a year ago.
Enact Reports Second Quarter 2024 Results and Announces Quarterly Dividend
04:15pm, Wednesday, 31'st Jul 2024
GAAP Net Income of $184 million , or $1.16 per diluted share Adjusted Operating Income of $201 million , or $1.27 per diluted share Return on Equity of 15.4% and Adjusted Operating Return on Equity of
- Sickle cell disease affects approximately 100,000 patients in the U.S. annually and is a debilitating and life-threatening condition with high unmet need - Current conditioning with non-targeted c
Enact Holdings, Inc. (ACT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
11:06am, Wednesday, 24'th Jul 2024
Enact Holdings (ACT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Enact Holdings: Defensive Play In A Corner Of The Housing Market
04:32am, Sunday, 21'st Jul 2024
Enact Holdings, a mortgage insurance company, has outperformed the S&P 500 index over a two-year period in spite of low mortgage originations. However, the pace of gains has slowed, and the companies
Can Enact Holdings (ACT) Keep the Earnings Surprise Streak Alive?
01:11pm, Wednesday, 10'th Jul 2024
Enact Holdings (ACT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Enact to Host Second Quarter 2024 Earnings Call August 1st
09:05am, Tuesday, 09'th Jul 2024
RALEIGH, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its second quarter earnings release after the market closes on July 31, 2024. Enact
Enact Completes XOL Reinsurance Transaction as Part of its Diversified Credit Risk Transfer Program
04:10pm, Thursday, 27'th Jun 2024
Secures approximately $90 million of excess of loss reinsurance coverage from panel of reinsurers Secures approximately $90 million of excess of loss reinsurance coverage from panel of reinsurers
MTG or ACT: Which Multiline Insurance Stock is Better-Positioned?
10:45am, Wednesday, 19'th Jun 2024
Let's see how MGIC Investment (MTG) and Enact Holdings (ACT) fare in terms of some of the key metrics.
5 Stocks With Recent Dividend Hikes to Watch
09:16am, Friday, 07'th Jun 2024
Five stocks with recent dividend hike are: ACT, SEIC, NTAP, RY, DCI.
